Atlas Trials

The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer

Clinical trial NCT06929650 · RECRUITING

Trial details

NCT number
NCT06929650
Sponsor
University Health Network, Toronto
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Thyroid NoduleThyroid Cancer
Start date
2023-04-20
Primary completion
2025-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.